ROBERT A GATENBY, MD
Radiology at Campbell Ave, Tucson, AZ
License number
Arizona 25441
Category
Radiology
Type
Diagnostic Radiology
Address
Address
1501 N Campbell Ave, Tucson, AZ 85724
Phone
(520) 694-4034
(520) 694-0216 (Fax)
(520) 874-7400
(520) 874-3425 (Fax)
(520) 694-0216 (Fax)
(520) 874-7400
(520) 874-3425 (Fax)
Personal information
See more information about ROBERT A GATENBY at radaris.comName
Address
Phone
6551 Longfellow Dr, Tucson, AZ 85718
Organization information
See more information about ROBERT A GATENBY at bizstanding.comRobert Gatenby MD
1501 N Campbell Ave, Tucson, AZ 85724
Industry:
Radiology
Phone:
(520) 626-6100 (Phone)
Robert Arthur Gatenby
Professional information
See more information about ROBERT A GATENBY at trustoria.com
Robert A Gatenby, Tucson AZ
Robert A Gatenby, Tucson AZ
Specialties:
Radiologist
Address:
1501 N Campbell Ave, Tucson, AZ 85724
12902 Magnolia, Tampa, FL 33612
12902 Magnolia, Tampa, FL 33612
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
Board certifications:
American Board of Radiology Certification in Diagnostic Radiology (Radiology)
Robert Arthur Gatenby, Tucson AZ
Robert Arthur Gatenby, Tucson AZ
Specialties:
Radiology, Diagnostic Radiology
Work:
University Medical Center - Tucson
1501 N Campbell Ave, Tucson, AZ 85724
1501 N Campbell Ave, Tucson, AZ 85724
Education:
University of Pennsylvania(1977) Internal Medicine
Therapy Of Proliferative Disorders By Direct Irradiation Of Cell Nuclei With Tritiated Nuclear Targetting Agents
Therapy Of Proliferative Disorders By Direct Irradiation Of Cell Nuclei With Tritiated Nuclear Targetting Agents
US Patent:
2003012, Jul 3, 2003
Filed:
Sep 16, 2002
Appl. No.:
10/221969
Inventors:
Robert Gatenby - Tucson AZ, US
International Classification:
A61K051/00, A61K048/00
US Classification:
514/044000, 424/001730
Abstract:
The present invention provides methods of treating proliferative disorders in vivo by the direct administration of tritium to target cell nuclei. Tritium is administered to target cell nuclei by a tritiated nuclear targeting agent, which is directed to the target cell nucleus where it associates with the cell's DNA. The close association of the tritiated nuclear targeting agent with the target cell DNA allows the low-energy beta particle emitted by the tritium to damage to the target cell DNA and kill the cell. Tritiated nuclear targeting agents can also be delivered to the target cells by structures such as liposomes, micelles and microcapsules.